MIRA INFORM REPORT

 

 

Report Date :

11.09.2014              

 

IDENTIFICATION DETAILS

 

Name :

FUKUDA RYU CO LTD

 

 

Registered Office :

1-5-11 Nishi-Tenma Kitaku Osaka 530-0047

 

 

Country :

Japan

 

 

Financials (as on) :

30.04.2013

 

 

Date of Incorporation :

December 1951

 

 

Com. Reg. No.:

1200-01-069761

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacture of herbal medicines, raw materials, extracts, spices, health foods

 

 

No. of Employees :

36

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy

Source : CIA

Company name and address

 

FUKUDA RYU CO LTD

REGD NAME:    Fukuda Ryu KK

MAIN OFFICE:  1-5-11 Nishi-Tenma Kitaku Osaka 530-0047 JAPAN

                                    Tel: 06-6364-5861      Fax: 06-6364-6562

 

URL:                 http://www.fukudaryu.co.jp

E-Mail address: (thru the URL)

 

 

ACTIVITIES  

 

Mfg of herbal medicines, raw materials, extracts, spices, health foods

 

 

BRANCHES   

 

Nil

 

 

OVERSEAS   

 

China

 

 

FACTORIES  

 

At the caption address

 

 

OFFICERS

 

KAZUHIRO FUKUDA, PRES       Kazutoshi Hama, dir

Hifumi Fukuda, dir                      Tomoko Fukuda, dir

                       

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIR                 A/SALES          Yen 1,626 M

PAYMENTSNo complaints         CAPITAL           Yen 48 M

TREND UP                    WORTH            Yen 672 M      

STARTED         1951                 EMPLOYES      36

 

 

COMMENT    

 

MFR OF HERBAL MEDICINES & EXTRACTS.

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY

BUSINESS ENGAGEMENTS.

                       

NORMAL TERMS.

 

 

HIGHLIGHTS

           

            The subject company was established by Ryutaro Fukuda in order to make most of his experience in the subject line of business.  Kazuhiro is his son, who took the pres office in Apr 2005.  This is a specialized mfr of herbal medicines, raw materials, extracts, spices, functional foods, health foods, other.  Materials are imported mainly from China (80%), other from India, Korea, Taiwan, Vietnam, other.  Clients include pharmaceutical mfrs, wholesalers, other.

 

 

FINANCIAL INFORMATION

           

            The sales volume for Apr/2013 fiscal term amounted to Yen 1,626 million, a 1% up from Yen 1,613 million in the previous term.  The recurring profit was posted at Yen 32 million and the net profit at Yen 23 million, respectively, compared with Yen 24 million recurring profit and Yen 21 million net profit, respectively, a year ago.

 

            For the term that ended Apr 2014 the recurring profit was projected at Yen 35 million and the net profit at Yen 25 million, respectively, on a 5% rise in turnover, to Yen 1,700 million.  Final results are yet to be released.

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:  Dec 1951

Regd No.:         1200-01-069761 (Osaka-Kitaku)

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         24,300 shares

Issued:                6,075 shares

Sum:                   Yen 48.6 million

Major shareholders (%): Kazuhiro Fukuda & families (--100)

No. of shareholders: 7

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Manufactures herbal medicines, raw material, extracts, functional foods, health foods, spices, other (--100%)

 

Clients: [Mfrs, wholesalers] Matsuura Medicine, Nippon Funmatsu Yakuhin Co, Nagakura Kampo, JOU, Uchida Wakanyaku Ltd, other 

No. of accounts: 300

Domestic areas of activities: Nationwide

Suppliers: [Mfrs, wholesalers] Imports from China (80%), other from Taiwan, India, Korea, Thailand, India, Vietnam, Indonesia, Africa, Europe, North/South America, other

Domestically from Uchida Wakanyaku, (10%), other

 

Payment record: no complaints

 

Location: Business area in Osaka.  Office premises at the caption address are owned and maintained satisfactory.

 

Bank References:

MUFG (Tanjinbashi)

Resona Bank (Kitahama)

Relations: Satisfactory

 

 

 

FINANCES

 

(In Million Yen)

       Terms Ending:

30/04/2014

30/04/2013

30/04/2012

30/04/2011

Annual Sales

　

1,700

1,626

1,613

1,599

Recur. Profit

　

35

32

24

　

Net Profit

　

25

23

21

23

Total Assets

　

　

2,378

2,336

2,288

Current Assets

　

　

1,272

1,271

　

Current Liabs

　

　

1,046

1,047

　

Net Worth

　

　

672

654

637

Capital, Paid-Up

　

　

48

48

48

Div.Ttl in Million (¥)

　

　

4.77

4.77

4.77

<Analytical Data>

　

(%)

(%)

(%)

(%)

    S.Growth Rate

　

4.55

0.81

0.88

4.92

    Current Ratio

　

..

121.61

121.39

..

    N.Worth Ratio

　

..

28.26

28.00

27.84

    R.Profit/Sales

　

2.06

1.97

1.49

..

    N.Profit/Sales

　

1.47

1.41

1.30

1.44

    Return On Equity

　

..

3.42

3.21

3.61

 

Notes: Forecast (or estimated) figures for the 30/04/2014 fiscal term.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.82

UK Pound

1

Rs.98.14

Euro

1

Rs.78.65

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

PDT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.